Golden State Equity Partners’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
15,112
+11,983
| +383% | +$827K | 0.19% | 134 |
|
|
2025
Q1 | $217K | Sell |
3,129
-17
| -0.5% | -$1.18K | 0.04% | 396 |
|
|
2024
Q4 | $271K | Buy |
3,146
+2,410
| +327% | +$207K | 0.05% | 355 |
|
|
2024
Q3 | $87.6K | Sell |
736
-2,841
| -79% | -$338K | 0.05% | 295 |
|
|
2024
Q2 | $511K | Buy |
+3,577
| New | +$511K | 0.11% | 209 |
|
|
2023
Q4 | $367K | Buy |
3,544
+23
| +0.7% | +$2.38K | 0.09% | 237 |
|
|
2023
Q3 | $320K | Sell |
3,521
-125
| -3% | -$11.4K | 0.09% | 244 |
|
|
2023
Q2 | $295K | Sell |
3,646
-492
| -12% | -$39.8K | 0.08% | 277 |
|
|
2023
Q1 | $329K | Buy |
+4,138
| New | +$329K | 0.18% | 134 |
|